A targeted screening method for non-invasive vascular assessment of the lower limb
© The Author(s). 2016
Received: 11 August 2016
Accepted: 30 November 2016
Published: 7 December 2016
Podiatrists routinely perform non-invasive lower limb vascular assessment, however frequently cite time as a major barrier in performing regular assessment. The aim of this study was to develop an evidence-based vascular assessment method to guide podiatrists’ decision-making processes to aid in timely vascular assessment in at risk populations.
The sample underwent brachial pressure measurement, ankle pressures, toe pressure and Doppler waveform with colour duplex ultrasound (CFDU) used as the reference standard. Both the targeted screening method and the American Heart Association (AHA) guideline for vascular screening were then applied to the data set and sensitivity and specificity of each method was calculated.
One hundred nineteen participants were included. Sensitivity of the targeted screening method (62%, 95% CI 47.17–75.35) was higher than the AHA method (49%, 95% CI 34.75–63.40), however, specificity of the AHA method (94%, 95% CI 85.62–98.37) was higher than the targeted screening method (85%, 95% CI 74.26–92.60). Diagnostic accuracy was similar with the AHA method yielding 74% diagnostic accuracy and the targeted screening method 73%.
The targeted screening method and the broad international guideline demonstrated similar accuracy, however clinicians may save time using the targeted screening method. This study highlights the difficulties in obtaining accuracy in lower limb vascular assessment in general.
KeywordsNon-invasive vascular assessment Podiatrist
Identifying the presence and extent of peripheral arterial disease (PAD) through accurate lower limb vascular assessment is essential for reducing morbidity and mortality associated with the disease . Through early identification of PAD, complications such as ulceration, gangrene and amputation can be reduced or avoided using aggressive risk factor modification, provision of ongoing foot care and foot care education [2–4]. It has been estimated that up to 90% of amputations are preventable [2–4] with adequate foot screening including vascular assessment playing a vital role in reducing complications and improving clinical outcomes . Accurate and effective vascular assessment requires a complex reasoning process which takes into account a patient’s vascular risk factors as well as an awareness of the effect of co-morbidities on the clinical efficacy of assessments techniques, and, subsequent interpretation of results to formulate an evidence-based management plan.
Podiatrists play a central role in conducting non-invasive lower limb vascular assessments in the general population. We have recently demonstrated that on average, podiatrists perform two vascular assessments per day, however, the type of the testing that is conducted during the assessments is extremely varied and, potentially inadequate for accurate PAD screening . There are several available international guidelines for performing screening for PAD, including National Institute of Health and Care Excellence (NICE) guidelines and the American Heart Association (AHA) guidelines. Both of these guidelines recommend the use of ABI as a primary screening tool for populations at risk of PAD [3, 4]. However the uptake of these recommendations into clinical practice appears to be inconsistent . Time required to perform recommended objective testing, particularly the ankle-brachial index (ABI) is the most widely nominated barrier to conducting appropriate vascular assessment, [2, 5] with clinicians often relying on more quickly applied assessments including continuous wave Doppler (CWD) and pulse palpation. In addition there is growing evidence of the reduced accuracy of the ABI for detecting PAD in specific populations including those at risk of medial arterial calcification (MAC), particularly when co-existing with PAD and of a more distal distribution of atherosclerotic lesions including diabetes, renal disease, and older aged cohorts . In such populations further alternate testing including the toe brachial index (TBI) is frequently required, adding to the time to complete an assessment. Our recent research suggests more quickly applied vascular assessment techniques such as the TBI and CWD may be suitable for use as first line assessment techniques for PAD assessment, particularly in older people and those with diabetes [7, 8]. The aim of this study was to determine if a targeted version of current guidelines in which the TBI was used initially in patient populations in which the ABI is known to be problematic could achieve similar diagnostic accuracy to testing protocols where the ABI is used as the primary objective testing method for all people at risk of PAD.
The CFDU and vascular assessment results of this data set has previously been used to investigate diagnostic accuracy of vascular testing methods in specific populations [7, 8]. Participants were recruited on a volunteer basis from two different locations, a community health centre in Newcastle, NSW, and a private podiatry practice in Nelson Bay NSW. Participants who fitted the AHA guidelines for peripheral vascular screening were eligible to participate; i.e. patients over the age of 65, patients above the age of 50 with the presence of diabetes or currently smoking or patients with exertional leg pain. Participants who were unable to comply with the testing protocol or who had a vasospastic disorder preventing TBI measurement were excluded. Testers included three vascular sonographers who performed: colour duplex ultrasound (CFDU), ankle, brachial and toe pressure measurements, at a private clinic in Newcastle. Methodology for vascular screening has previously been described [7, 8]. CFDU reliability has previously been assessed  and found to be acceptable.
The AHA guideline was applied to the entire data set by a single researcher (PT) i.e. the ABI result was used unless it exceeded 1.4 in which case it was replaced by the TBI. These results were used to determine the diagnostic accuracy of the AHA guidelines for detecting PAD using CFDU as the reference standard. The targeted method was also applied to the entire data set by a single researcher (PT) i.e. the ABI was used unless diabetes or renal failure was present or participants were aged over 75 years in which case the TBI value was used. These results were used to determine the diagnostic accuracy of the targeted screening method for detecting PAD using CFDU as a reference standard.
For statistical calculations relating to diagnostic accuracy, presence of PAD was defined as one or more arteries with >50% stenosis [13, 14]. Sensitivity, specificity, positive and negative predictive values and likelihood ratios were calculated with 95% confidence intervals for the AHA screening method and the targeted screening method. Calculations of diagnostic accuracy were performed using Microsoft Excel.
Total participants (N)
Males n (%)
Females n (%)
Age Range (Years)
Diabetes n (%)
Mean Age (years)
73.1 (SDA 7.2)
Incompressible ankle pressure n (%)
Distal PAD n (%)
Proximal PAD n (%)
Distal & Proximal PAD n (%)
PAD n (%)
Proximal Occlusions n (%)
Distal Occlusions n (%)
Targeted screening method
95% confidence interval
95% confidence interval
47.17 to 75.35
34.75 to 63.40
74.26 to 92.60
85.62 to 98.37
Positive predictive value
2.25 to 7.66
68.34 to 96.11
Negative Predictive Value
0.31 to 0.65
60.60 to 80.18
Positive likelihood ratio
2.25 to 7.66
3.09 to 22.45
Negative likelihood ratio
0.31 to 0.65
0.41 to 0.71
This study investigated whether diagnostic accuracy of lower limb vascular screening for PAD can be achieved using a targeted version of current guidelines designed to reduce the time taken to perform a vascular assessment. The results of this study indicate that the targeted method had a higher sensitivity for PAD than when tests were conducted in accordance with the AHA guidelines, however lower specificity. Overall the two methods had almost identical diagnostic accuracy (AHA method 74%, targeted method 73%). Although the ABI has been shown to have good sensitivity and excellent specificity across the general population  our recent research suggests uptake of the test by podiatrists is poor, with the time associated with performing the test cited as one of the most common reasons for this . Performing an ABI requires two ankle pressures per limb (dorsalis pedis and posterior tibial). The targeted method we have proposed increases the number of people who have a TBI performed as the initial screening test. A TBI is quicker to perform due to the need for only one toe pressure per limb to be taken. In addition the targeted method ensures there will rarely be a time that clinicians need to perform more than one form of lower limb pressure measurement in a single testing session. Both changes are likely to reduce the amount of time needed to perform objective non-invasive vascular testing.
Current evidence suggests podiatrists rely on subjective findings including pulse palpation and visual appearance to identify PAD, while objective assessment is often limited to CWD which we have shown to have poor reliability [2, 15]. The method we have developed offers a potential mechanism to improve the diagnostic accuracy of vascular assessments currently performed by podiatrists by targeting the type of objective test to be used using patient medical history. In addition, increasing the use of the TBI, which has been shown to have high reliability in diabetes and non diabetes cohorts for initial testing for PAD , offers a more time efficient objective test that may be more widely adopted in clinical practice. There is also growing evidence that tests such as the TBI may be a valuable adjunct to clinical practice and could be more widely used, particularly in populations at risk of foot complications .
Of note our study demonstrates that neither screening method yielded a very high level of diagnostic accuracy, which re-enforces the difficulty of non-invasive lower limb vascular assessment in populations at risk of PAD. Further investigation into the diagnostic accuracy of non-invasive vascular assessment testing methods should be undertaken to ascertain what testing should be performed in populations at risk of PAD. The diagnostic accuracy of both the ABI and TBI should be further elucidated using gold standard imaging as a reference standard. Further research that helps guide clinical practice could facilitate increased efficiency and increased accuracy when conducting vascular assessments, reducing the number of undiagnosed cases of PAD and ensuring timely intervention and appropriate management to prevent complications such as ulceration and infection and amputation.
The results of this study need to be considered in light of some significant limitations. The accuracy of both screening tools relies upon the individual accuracy of each diagnostic test. Each of the included tests, ABI and TBI have their own limitations with accuracy. The ABI in particular has been shown to have limited diagnostic accuracy in populations at risk of PAD. The reference standard used, CFDU, whilst a valid form of diagnostic imaging, and used extensively clinically, also has limitations with diagnostic accuracy. Ideally angiography should be used as a reference standard however due to the prospective nature of the data collection for this study this was not possible. Future research should use retrospective data and use the gold standard in vascular imaging, angiography as a reference standard.
Modification of current international guidelines based on medical history to reduce the time burden of lower limb vascular assessment in clinical practice yields similar diagnostic accuracy to assessment undertaken in accordance with the guidelines. This study highlights the difficulties in obtaining accuracy in lower limb vascular assessment in at risk populations and clinicians should consider using the TBI as an alternate screening tool given its higher level of accuracy and predictive capabilities.
Many thanks to Kate Carroll, Bella Schlacter, Patrick Tehan and Krista Sturday along with Dr Alan Bray and Richard Rounsley for their valued input and assistance with data collection.
Funding support for this study was provided by the University of Newcastle new staff grant and early career researcher grant.
Availability of data and materials
De-identified data is held securely with the lead author and may be available upon request.
PT and VC developed the methodology of the study, PT completed data collection and input, PT and VC performed data analysis, PT developed the manuscript and both authors approved the final manuscript.
Neither authors, PT or VC have any conflicts or competing interests to declare.
Consent for publication
Ethics approval and consent to participate
This research was completed under the ethical approval of the University of Newcastle ethics committee approval number H-2013-0152 and Hunter New England Area Health service research ethics committee approval number 13/02/20/5.05 and NSW HREC LNR/13/HNE/18.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Vaidya A, Joore MA, Cate-Hoek AJ, Severens JL. Screen or not to screen for peripheral arterial disease: guidance from a decision model. BMC Public Health. 2014;14(89). doi:10.1186/1471-2458-14-89.
- Tehan P, Chuter VH. Vascular assessment techniques of podiatrists in Australia and New Zealand: a web-based survey. J Foot Ankle Res. 2015;8(71)
- Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WRC, Olin JW, Puschett JB, et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic). J Vasc Interv Radiol. 2006;17(9):1383–98.View ArticlePubMedGoogle Scholar
- (NICE) NIoHaCE. Peripheral Arterial Disease: Diagnosis and Management CG147. National Institute of Health and Care Excellence (NICE); 2012. https://www.nice.org.uk/guidance/qs52/resources.
- Chen PY, Lawford KM, Shah N, Pham J, Bower V. Perceptions of the ankle brachial index amongst podiatrists registered in Western Australia. J Foot Ankle Res. 2012;5(19)
- Aerden D, Massaad D, von Kemp K, van Tussenbroek F, Debing E, Keymeulen B, Van den Brande P. The ankle–brachial index and the diabetic foot: a troublesome marriage. Ann Vasc Surg. 2011;25(6):770–7.View ArticlePubMedGoogle Scholar
- Tehan P, Bray A, Chuter VH. Non-invasive vascular assessment in the foot with Diabetes: sensitivity and specificity of the ankle brachial index, toe brachial index and continuous wave Doppler in detecting peripheral arterial disease. J Diabetes Complications. 2016;30:155–60.View ArticlePubMedGoogle Scholar
- Tehan P, Bray A, Keech R, Rownsley R, Carruthers A, Chuter VH. Sensitivity and specificity of the toe brachial index in detecting peripheral arterial disease: initial findings. J Ultrasound Med. 2015;34:1737–43.View ArticlePubMedGoogle Scholar
- Williams DT, Harding KG, Price P. An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes. Diabetes Care. 2005;28(9):2206–10.View ArticlePubMedGoogle Scholar
- Xu D, Li J, Zou L, Xu Y, Hu D, Pagoto S, Ma Y. Sensitivity and specificity of the ankle-brachial index to diagnose peripheral artery disease: a structured review. Vasc Med. 2010;15(5):361–9.View ArticleGoogle Scholar
- Alavi A, Sibbald RG, Nabavizadeh R, Valaei F, Coutts P, Mayer D. Audible handheld Doppler ultrasound determines reliable and inexpensive exclusion of significant peripheral arterial disease. Vascular. 2015.
- du Ro H, Moon HJ, Kim JH, Lee KM, Kim SJ, Lee DY. Photoplethysmography and continuous-wave Doppler ultrasound as a complementary test to ankle-brachial index in detection of stenotic peripheral arterial disease. Angiology. 2013;64(4):314–20.View ArticleGoogle Scholar
- Sacks D, Robinson ML, Marinelli DL, Perlmutter GS. Peripheral arterial Doppler ultrasonography: diagnostic criteria. J Ultrasound Med. 1992;11(3):95–103.View ArticlePubMedGoogle Scholar
- Koelemay MJW, Den Hartog D, Prins MH, Kromhout JG, Legemate DA, Jacobs MJHM. Diagnosis of arterial disease of the lower extremities with duplex ultrasonography. Br J Surg. 1996;83(3):404–9.View ArticlePubMedGoogle Scholar
- Tehan PE, Chuter VH. Use of hand-held Doppler ultrasound examination by podiatrists: a reliability study. J Foot Ankle Res. 2015;8(36).
- Sonter J, Chuter V, Casey S. Intra-tester and inter-tester reliability of toe pressure measurements in people with and without diabetes performed by podiatric physicians. J Am Podiatr Assoc. 2015;105(3):201–8.View ArticleGoogle Scholar
- Sonter J, Ho A, Chuter VH. The predictive capacity of toe blood pressure and the toe-brachial index for foot wound healing and amputation: A systematic review and meta-analysis. Wound Pract Res. 2014;22(4):208–17.Google Scholar